What to Know About Rising Rates of ‘Early-Onset’ Cancer
Cancer diagnoses in people younger than 50 are on the rise. Yale experts are recognizing a need for more research and personalized care.
Cancer diagnoses in people younger than 50 are on the rise. Yale experts are recognizing a need for more research and personalized care.
Dr. Hilary Robbins, an epidemiologist with the International Agency for Research on Cancer, and Dr. Brendon Stiles, chief of Thoracic Surgery and Surgical Oncol …
In a randomized trial of standard-risk adults, metformin decreased severe acute respiratory syndrome coronavirus 2 viral loads by an average of 0.56 log10
This case report illustrates the need for real-time integration of proteogenomic data from laser microdissected tumor specimens and dynamic biopsy testing
Tyrosine kinase inhibitors and immune checkpoint inhibitors (ICIs), each requiring testing for precision biomarkers, have recently been approved in the adjuvant setting. We assessed the…
Comprehensive genomic profiling (CGP) uses next-generation sequencing methods to detect specific molecular abnormalities in a patient’s tumor. CGP can disclose biomarkers at nucleotide-level resolution and…
PURPOSE Clinical trials of novel and targeted agents increasingly require biomarkers for eligibility. Precision oncology continues to evolve, but challenges hamper broad use of molecular…
PURPOSE Many patients with actionable driver oncogenes (ADOs) are never identified and thus never receive targeted treatment. This study evaluated the economic impact and the…
Abstract. The Veterans Health Administration is the largest integrated provider of cancer services in the nation, with approximately 50,000 new cancer cases dia
Quantification of the precision oncology landscape and clinical actionability in patients with cancer shows an increase in the fraction of genomic biomarkers of response to…